query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.smh.com.au/national/life-changing-diabetes-treatment-approved-20260527-p600z7.html
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
Life-changing diabetes treatment approved
A new world-first treatment for type 1 diabetes has been approved in Australia.
Ähnliche Seiten
Life-changing diabetes treatment approved
https://www.watoday.com.au/national/life-changing-diabetes-treatment-approved-20260527-p600z7.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Life-changing diabetes treatment approved
https://www.brisbanetimes.com.au/national/life-changing-diabetes-treatment-approved-20260527-p600z7.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Life-changing diabetes treatment approved
https://www.theage.com.au/national/life-changing-diabetes-treatment-approved-20260527-p600z7.html?ref=rss&utm_medium=rss&utm_source=rss_national
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/newcelx-ltd-submits-pre-ind-package-to-the-fda-for-ncel-101-for-the-treatment-of-type-1-diabetes/2352552
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/jascayd-nerandomilast-approved-in-japan-advancing-global-access-to-a-new-ipf-and-ppf-treatment/2345863
Bayer Wins FDA Priority Review For Kerendia In Chronic Kidney Disease With Type 1 Diabetes
https://www.finanznachrichten.de/nachrichten-2026-05/68557764-bayer-wins-fda-priority-review-for-kerendia-in-chronic-kidney-disease-with-type-1-diabetes-020.htm
Please enable JavaScript to continue using this application.